62 results
Page 3 of 4
DEF 14A
7kzdrtfdp7fcr rlqxd
24 Apr 20
Definitive proxy
4:14pm
10-K
d1hopzbb9p
10 Mar 20
Annual report
4:20pm
8-K
EX-99.1
9z8nfu9jus7
10 Mar 20
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Results
4:10pm
10-Q
s1jaujz0i
12 Nov 19
Quarterly report
4:31pm
8-K
EX-99.1
oqrxpuydzsh4z2
12 Nov 19
Satsuma Pharmaceuticals Reports Third Quarter 2019 Financial and Business Results
4:16pm
8-K
EX-3.2
xn6 v52f9osa
17 Sep 19
Satsuma Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
4:11pm
424B4
9ia0t0vdmmplz8
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
ylc9w6wa8g toiv1
3 Sep 19
IPO registration (amended)
6:12am
S-1
EX-10.2
yprohdy3o88af1zug
16 Aug 19
IPO registration
5:15pm
S-1
EX-3.5
e1wmx6ym0eskv
16 Aug 19
IPO registration
5:15pm
S-1
ro2u5d
16 Aug 19
IPO registration
5:15pm
S-1
EX-10.1
bgpagewv4d6fj
16 Aug 19
IPO registration
5:15pm
CORRESP
ewxb j2dtbaywyhubsbz
16 Aug 19
Correspondence with SEC
12:00am
UPLOAD
fymvbwbv
12 Aug 19
Letter from SEC
12:00am
DRS/A
EX-10.2
era tf5qlkd0zg6zg
2 Aug 19
Draft registration statement (amended)
12:00am
DRSLTR
fvwpejp iv5guk
2 Aug 19
Correspondence regarding draft registration statement
12:00am
DRS/A
EX-10.1
8qic 9z8b
2 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-3.5
ivuwwz
2 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
cobp86vhxmmzz
2 Aug 19
Draft registration statement (amended)
12:00am